Chemours Co
▲ 1 upgrades / ▼ 1 downgrades / 3 reiterations from 4 firms
Nov 2, 2026 (7 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 20, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Oct 14, 2026 | Mizuho | downgrade | Outperform → Neutral | — | 52% |
| Oct 13, 2026 | Barclays | initiate | — → Equal-Weight | — | 53% |
| Oct 5, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Sep 30, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Aug 13, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 54% |
| Aug 13, 2026 | BMO Capital | maintain | Outperform → Outperform | — | 53% |
| Aug 10, 2026 | UBS | downgrade | Buy → Neutral | — | 54% |
| Aug 6, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Aug 6, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jul 1, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| May 21, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 54% |
| May 11, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| May 11, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 8, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Apr 28, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Apr 9, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Apr 9, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Mar 5, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Feb 25, 2026 | Goldman Sachs | maintain | Neutral → Neutral | $18 | 54% |
| Feb 23, 2026 | UBS | maintain | Buy → Buy | $23 | 54% |
| Feb 23, 2026 | BMO Capital | maintain | Outperform → Outperform | $19 | 53% |
| Feb 23, 2026 | JP Morgan | maintain | Neutral → Neutral | $17 | 54% |
| Feb 23, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $17 | 54% |
| Jan 21, 2026 | Truist Securities | maintain | Buy → Buy | $21 | 54% |
| Dec 3, 2025 | JP Morgan | maintain | Neutral → Neutral | $13 | 54% |
| Nov 11, 2025 | UBS | maintain | Buy → Buy | $18 | 54% |
| Nov 10, 2025 | Truist Securities | maintain | Buy → Buy | $18 | 54% |
| Nov 10, 2025 | RBC Capital | maintain | Outperform → Outperform | $17 | 55% |
| Oct 16, 2025 | Mizuho | maintain | Outperform → Outperform | $18 | 52% |
| Oct 6, 2025 | UBS | maintain | Buy → Buy | $21 | 54% |
| Sep 23, 2025 | Mizuho | maintain | Outperform → Outperform | $19 | 52% |
| Sep 16, 2025 | Truist Securities | maintain | Buy → Buy | $21 | 54% |
| Jul 15, 2025 | Mizuho | maintain | Outperform → Outperform | $16 | 52% |
| Jul 3, 2025 | RBC Capital | maintain | Outperform → Outperform | $15 | 55% |
| May 28, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $13 | 53% |
| May 14, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $14 | 54% |
| May 12, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $15 | 54% |
| May 8, 2025 | RBC Capital | maintain | Outperform → Outperform | $14 | 55% |
| May 7, 2025 | UBS | maintain | Buy → Buy | $17 | 54% |
| Apr 14, 2025 | Truist Securities | maintain | Buy → Buy | $22 | 54% |
| Apr 1, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $16 | 53% |
| Mar 27, 2025 | Mizuho | upgrade | Neutral → Outperform | $19 | 52% |
| Feb 24, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $19 | 53% |
| Feb 19, 2025 | BMO Capital | maintain | Outperform → Outperform | $27 | 53% |
| Jan 28, 2025 | Truist Securities | initiate | — → Buy | $27 | 54% |
| Jan 13, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $22 | 54% |
| Jan 7, 2025 | Mizuho | maintain | Neutral → Neutral | $21 | 52% |
| Jan 7, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $21 | 54% |
| Dec 12, 2024 | RBC Capital | reiterate | Outperform → Outperform | $25 | 55% |
No cross-platform signals in the last 90 days